Coliseum Acquisition Corp. Files DEFA14A Proxy Materials

TL;DR

Coliseum Acquisition Corp. filed proxy materials, likely for shareholder votes. Keep an eye on upcoming announcements.

AI Summary

Coliseum Acquisition Corp. filed a Definitive Additional Materials filing (DEFA14A) on December 20, 2024. This filing is related to proxy statements and is not a preliminary proxy statement. The company is incorporated in Delaware and has a fiscal year end of December 31.

Why It Matters

This filing indicates that Coliseum Acquisition Corp. is providing additional materials to shareholders regarding proxy matters, which could pertain to upcoming votes or corporate actions.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement update and does not inherently indicate significant new risks.

Key Players & Entities

• Coliseum Acquisition Corp. (company) — Registrant
• 0001104659-24-130346 (filing_id) — Accession Number
• 20241220 (date) — Filing Date
• 20241219 (date) — Date as of Change
• DEFA14A (document_type) — Form Type
• 1180 NORTH TOWN CENTER DRIVE, SUITE 100, LAS VEGAS, NV 89144 (address) — Business and Mail Address

FAQ

Key Financial Figures

• $0.001 — f one Class A ordinary share, par value $0.001 per share, and one-third of one redeema
• $11.50 M — ordinary share at an exercise price of $11.50 MITAW The Nasdaq Stock Market LLC Ind
• $11.39 — price per public share is approximately $11.39. The Company has determined to allow
• $17,500 — initial extension to December 31, 2024, $17,500, and (ii) one business day following th
• $75,000 — pect to each such additional extension, $75,000; provided that such Extension would not

Filing Documents

• tm2431660d1_defa14a.htm (DEFA14A) — 42KB
• 0001104659-24-130346.txt ( ) — 44KB

01

Item 8.01 Other Events. As previously disclosed, Coliseum Acquisition Corp. (the " Company ") has scheduled an extraordinary general meeting to be held at the offices of White & Case LLP at 9:00 a.m. on December 23, 2024, in connection with the Business Combination (as defined below) (the " Business Combination Meeting ") and an extraordinary general meeting to be held at the offices of White & Case LLP at 9:00 a.m. on December 23, 2024 to seek shareholder approval of the Extension (as defined below) (the " Extension Meeting " and, together with the Business Combination Meeting, the " Meetings "). Redemption Reversals Shareholders are entitled to submit their public shares for redemption in connection with both the Business Combination Meeting and the Extension Meeting. The redemption deadline in connection with the Meetings is December 19, 2024, at 5:00 p.m. ET. The estimated redemption price per public share is approximately $11.39. The Company has determined to allow redeeming shareholders to reverse their redemptions in connection with the Meetings through 5:00 p.m. ET on December 20, 2024 without the approval of Coliseum or its sponsor. Shareholders may request to reverse their redemption by contacting the Company's transfer agent, Continental Stock Transfer & Trust Company, at One State Street, 30th Floor, New York, New York 10004 (e-mail: spacredemptions@continentalstock.com ). Potential Purchases of Public Shares Certain third-party non-affiliated investors have indicated that they intend to purchase an aggregate of up to approximately 200,000 Public Shares in the open market prior to the Meetings and to not redeem such shares. No definitive agreements have been entered into for any such purchases and we cannot guarantee that such persons will purchase all or any of such indicated shares. Additional Information about the Business Combination and Where to Find it As previously disclosed, Coliseum entered into a Business Combination Agreement wi

Forward-looking statements generally are accompanied by words such as "may," "will," "anticipate,"

Forward-looking statements generally are accompanied by words such as "may," "will," "anticipate," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These statements are based on various assumptions, whether or not identified in this Current Report on Form 8-K or the exhibit hereto, and on the current expectations of RET's and Coliseum's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be viewed by any investor as, a guarantee, an assurance, a prediction or a definitive statement of factor probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of Coliseum, RET, and Holdco. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, market, financial, political and legal conditions; the ability of the parties to successfully consummate the Business Combination; the ability to satisfy the conditions to the consummation of the Business Combination, including the approval of the Business Combination by Coliseum's shareholders and the satisfaction of the minimum cash condition; the amount of redemption requests made by Coliseum's public shareholders; the effect of the announcement and pendency of the Business Combination on RET's business; RET's ability to manage future growth; Holdco's ability to meet the listing standards of Nasdaq; the failure to obtain, maintain, adequately protect, or enforce RET's intellectual property rights; the numerous regulatory and legal requirements that RET will need to comply with to operate its business; the concentr

View Full Filing

View this DEFA14A filing on SEC EDGAR